Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Baseline documentation should occur before initiating any treatment, including standardized photographs under consistent lighting, hair density measurements if possible, and subjective assessments of current hair quality and scalp health
NICE-approved weight management interventions include: Dietary and lifestyle modification first-line approach for all patients Orlistat licensed medication for obesity (BMI 30 or 28 with comorbidities) GLP-1 receptor agonists including semaglutide (Wegovy) per NICE TA875 and liraglutide (Saxenda) with restrictions per NICE TA664, for specific patient groups Bariatric surgery for severe obesity meeting strict criteria The NHS emphasises that sustainable weight loss requires behavioural change, nutritional education, and increased physical activity
During lactation, the RDA is 2.8 mcg
Recommended dosing: Subcutaneous: 200500 mcg per injection once or twice daily, rotating sites
US$ 25.48
US$ 20.49
US$ 27.63
